glp-1 drug liraglutide may protect against dementia Alzheiemer's: Can a cognitive decline? Role of glucagon-like peptide-1 receptor

End-Users 17.8

References 1.Abdelmalek, M., Choi, J., Kim, Y., Seo, K., Hompesch, M., and Baek, S

Many complaints describe symptoms that go beyond expected transient nauseasuch as recurring vomiting, delayed gastric emptying, and episodes of severe stomach painwhich is part of why this litigation is unfolding as a coordinated proceeding

The origin and understanding of the incretin concept

Ozempic and Blood Clots and DVT Individuals are filing lawsuits against the manufacturer of Ozempi, alleging the drug increases a persons risk of developing deep vein thrombosis

Attorneys for Novo Nordisk, Ozempics manufacturer, want each plaintiff to have had a stomach emptying test to diagnose the disorder